Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 258 matches for

UK must step up its pandemic preparedness plans

PSI colleagues Professor Alice Norton, Professor Samantha Vanderslott and Professor Sir Peter Horby reflect on what the WHO Pandemic Agreement means for the UK, in a BMJ editorial.

New research reveals optimal time intervals for COVID-19 vaccine boosters

Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.

PSI-industry oral vaccine project aims to transform immunisation strategies

The project led by Professor Dame Sarah Gilbert is one of the winners of the first VaxHub Sustainable Platform Funding Call.

Bubonic plague treatment proven highly effective and safe in global first

Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague.

New WHO Collaborating Centre for Genomic Surveillance of Antimicrobial Resistance launched

Hosted by the Centre for Genomic Pathogen Surveillance at PSI, the new Centre will support efforts to tackle one of the most pressing global health challenges of our time.

HRH The Duke of Gloucester visits University of Oxford’s cutting-edge vaccine facilities

The visit to the Clinical BioManufacturing Facility and the laboratories of the Oxford Vaccine Group and Pandemic Sciences Institute showcased Oxford’s global leadership in medical science and innovation.

Construction begins on state-of-the-art research facility

The University of Oxford held a groundbreaking ceremony on Tuesday 24 June to celebrate the start of construction of the Cyrus Poonawalla Vaccines Research Building. The ceremony marks a significant milestone in Oxford’s mission to counter and constrain global health threats.

Online places still available for the International Pandemic Sciences Conference 2025

Online delegates will gain insights into pandemic preparedness from wherever they are in the world.

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The designation recognises the vaccine’s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.

CBF’s Omar El Muhanna awarded Jordanian Order for Distinction

As part of the Hashemite Kingdom of Jordan’s 79th Independence Day celebrations on 25 May, His Majesty King Abdullah II bestowed the King Abdullah II Ibn Al Hussein Order for Distinction upon Omar El Muhanna, Senior Operations and Strategy Executive at NDM’s Clinical BioManufacturing Facility.

Speakers announced for this year’s International Pandemic Sciences Conference

Meet the global experts set to present on the latest scientific advancements that will predict, identify and control future epidemic and pandemic threats.

Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.

New science partnership to strengthen Africa’s pandemic resilience

A groundbreaking research partnership is set to enhance Africa’s preparedness and response to future health crises.

RECOVERY trial team win NIHR Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

New paper outlines ethical issues in clinical metagenomics

This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.

Extended abstract deadline for International Pandemic Sciences Conference 2025

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025  has been extended to 23:59 GMT on Wednesday 26 February.

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.

New partnership to advance public health and life science research collaboration in West Africa

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Abstract submissions open for International Pandemic Sciences Conference 2025

Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.

Load More